Skip to main content
. 2016 Dec;37(12):2224–2230. doi: 10.3174/ajnr.A4917

Fig 3.

Fig 3.

Survival curves of patients stratified according to the pattern of tumor growth in the PRMR. Patients with “no growth” in the PRMR showed significantly improved survival (median survival, 837 days) compared with patients with “focal growth” (median survival, 582 days) and “global growth” (median survival, 344 days; P = .001).